The DOI matches its Crossref record; 361 of the 361 references it cites were found in a registry or an index.
Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
Open accessAbstract
The gut microbiota has been linked to the development of obesity and type 2 diabetes (T2D). The underlying mechanisms as to how intestinal microbiota may contribute to T2D are only partly understood. It becomes progressively clear that T2D is characterized by a chronic state of low-grade inflammation, which has been linked to the development of insulin resistance. Here, we review the current evidence that intestinal microbiota, and the metabolites they produce, could drive the development of insulin resistance in obesity and T2D, possibly by initiating an inflammatory response. First, we will summarize major findings about immunological and gut microbial changes in these metabolic diseases. Next, we will give a detailed view on how gut microbial changes have been implicated in low-grade inflammation. Lastly, we will critically discuss clinical studies that focus on the interaction between gut microbiota and the immune system in metabolic disease. Overall, there is strong evidence that the tripartite interaction between gut microbiota, host immune system and metabolism is a critical partaker in the pathophysiology of obesity and T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–361 of 361
Liu, C., Feng, X., Li, Q., Wang, Y., Li, Q., & Hua, M. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.028 · Cited by 470
Adipocyte lipolysis and insulin resistance
Morigny, P., Houssier, M., Mouisel, E., & Langin, D. (2016) · Biochimie · doi:10.1016/j.biochi.2015.10.024 · Cited by 469
SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling
Emanuelli, B., Peraldi, P., Filloux, C., Sawka-Verhelle, D., Hilton, D., & Van Obberghen, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15985 · Cited by 468
Lancaster, G. I., Langley, K. G., Berglund, N. A., Kammoun, H. L., Reibe, S., Estevez, E., Weir, J., Mellett, N. A., Pernes, G., Conway, J. R. W., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.014 · Cited by 466
Bile acids in glucose metabolism in health and disease
Shapiro, H., Kolodziejczyk, A. A., Halstuch, D., & Elinav, E. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171965 · Cited by 464
Mardinoglu, A., Wu, H., Bjornson, E., Zhang, C., Hakkarainen, A., Räsänen, S. M., Lee, S., Mancina, R. M., Bergentall, M., Pietiläinen, K. H., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.005 · Cited by 453
Chambers, E. S., Byrne, C. S., Morrison, D. J., Murphy, K. G., Preston, T., Tedford, C., Garcia-Perez, I., Fountana, S., Serrano-Contreras, J. I., Holmes, E., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318424 · Cited by 443
Yang, H., Youm, Y.-H., Vandanmagsar, B., Ravussin, A., Gimble, J. M., Greenway, F., Stephens, J. M., Mynatt, R. L., & Dixit, V. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000021 · Cited by 440
c-Jun N-terminal Kinase (JNK) Mediates Feedback Inhibition of the Insulin Signaling Cascade
Lee, Y. H., Giraud, J., Davis, R. J., & White, M. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208359200 · Cited by 438
Molofsky, A. B., Van Gool, F., Liang, H.-E., Van Dyken, S. J., Nussbaum, J. C., Lee, J., Bluestone, J. A., & Locksley, R. M. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.019 · Cited by 431
IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
Stritesky, G. L., Yeh, N., & Kaplan, M. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5948 · Cited by 417
Lassenius, M. I., Pietiläinen, K. H., Kaartinen, K., Pussinen, P. J., Syrjänen, J., Forsblom, C., Pörsti, I., Rissanen, A., Kaprio, J., Mustonen, J., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2197 · Cited by 413
Hong, E.-G., Ko, H. J., Cho, Y.-R., Kim, H.-J., Ma, Z., Yu, T. Y., Friedline, R. H., Kurt-Jones, E., Finberg, R., Fischer, M. A., et al. (2009) · Diabetes · doi:10.2337/db08-1261 · Cited by 411
Dror, E., Dalmas, E., Meier, D. T., Wueest, S., Thévenet, J., Thienel, C., Timper, K., Nordmann, T. M., Traub, S., Schulze, F., et al. (2017) · Nature Immunology · doi:10.1038/ni.3659 · Cited by 394
Jourdan, T., Godlewski, G., Cinar, R., Bertola, A., Szanda, G., Liu, J., Tam, J., Han, T., Mukhopadhyay, B., Skarulis, M. C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3265 · Cited by 388
Lagathu, C., Bastard, J.-P., Auclair, M., Maachi, M., Capeau, J., & Caron, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.013 · Cited by 385
T cell-mediated regulation of the microbiota protects against obesity
Petersen, C., Bell, R., Klag, K. A., Lee, S.-H., Soto, R., Ghazaryan, A., Buhrke, K., Ekiz, H. A., Ost, K. S., Boudina, S., et al. (2019) · Science · doi:10.1126/science.aat9351 · Cited by 385
Xiao, S., Fei, N., Pang, X., Shen, J., Wang, L., Zhang, B., Zhang, M., Zhang, X., Zhang, C., Li, M., et al. (2014) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12228 · Cited by 378
Kau, A. L., Planer, J. D., Liu, J., Rao, S., Yatsunenko, T., Trehan, I., Manary, M. J., Liu, T.-C., Stappenbeck, T. S., Maleta, K. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4877 · Cited by 372
McLaughlin, T., Liu, L.-F., Lamendola, C., Shen, L., Morton, J., Rivas, H., Winer, D., Tolentino, L., Choi, O., Zhang, H., et al. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.304636 · Cited by 364
Llewellyn, S. R., Britton, G. J., Contijoch, E. J., Vennaro, O. H., Mortha, A., Colombel, J.-F., Grinspan, A., Clemente, J. C., Merad, M., & Faith, J. J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.030 · Cited by 364 · cited 2×
“As diet is an important factor shaping the gut microbiota (304), dietary interventions (such as increasing plant-based fibers intake and reducing food additives such as artificial sweeteners) have been put forward as an attractive target to improve functional and compositional aspects of gut microbiota (146).”
BackgroundHendrikx, T., Duan, Y., Wang, Y., Oh, J.-H., Alexander, L. M., Huang, W., Stärkel, P., Ho, S. B., Gao, B., Fiehn, O., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317232 · Cited by 361
Low Production Capacity of Interleukin-10 Associates With the Metabolic Syndrome and Type 2 Diabetes
van Exel, E., Gussekloo, J., de Craen, A. J. M., Frölich, M., Bootsma-van der Wiel, A., & Westendorp, R. G. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1088 · Cited by 358
Association of Low Interleukin-10 Levels with the Metabolic Syndrome in Obese Women
Esposito, K., Pontillo, A., Giugliano, F., Giugliano, G., Marfella, R., Nicoletti, G., & Giugliano, D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021437 · Cited by 355
Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism
Mao, K., Baptista, A. P., Tamoutounour, S., Zhuang, L., Bouladoux, N., Martins, A. J., Huang, Y., Gerner, M. Y., Belkaid, Y., & Germain, R. N. (2018) · Nature · doi:10.1038/nature25437 · Cited by 353
Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young Adults
Fleischman, A., Shoelson, S. E., Bernier, R., & Goldfine, A. B. (2008) · Diabetes Care · doi:10.2337/dc07-1338 · Cited by 352
Regulation of inflammation by interleukin-4: a review of "alternatives"
Luzina, I. G., Keegan, A. D., Heller, N. M., Rook, G. A. W., Shea-Donohue, T., & Atamas, S. P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412214 · Cited by 351
Sanchez, M., Darimont, C., Drapeau, V., Emady-Azar, S., Lepage, M., Rezzonico, E., Ngom-Bru, C., Berger, B., Philippe, L., Ammon-Zuffrey, C., et al. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003875 · Cited by 351
Malla, M. A., Dubey, A., Kumar, A., Yadav, S., Hashem, A., & Abd_Allah, E. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02868 · Cited by 345
Interleukin‐23: as a drug target for autoimmune inflammatory diseases
Tang, C., Chen, S., Qian, H., & Huang, W. (2012) · Immunology · doi:10.1111/j.1365-2567.2011.03522.x · Cited by 337
Metabolic endotoxemia and diabetes mellitus: A systematic review
Gomes, J. M. G., Costa, J. D. A., & Alfenas, R. D. C. G. (2017) · Metabolism · doi:10.1016/j.metabol.2016.12.009 · Cited by 334
Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes
Donath, M. Y., Böni-Schnetzler, M., Ellingsgaard, H., & Ehses, J. A. (2009) · Physiology · doi:10.1152/physiol.00032.2009 · Cited by 330
Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept
for the D.E.S.I.R. Study Group, Amar, J., Serino, M., Lange, C., Chabo, C., Iacovoni, J., Mondot, S., Lepage, P., Klopp, C., Mariette, J., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2329-8 · Cited by 327
Chassaing, B., Ley, R. E., & Gewirtz, A. T. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.033 · Cited by 326 · cited 1×
“TLR5 knock out in intestinal epithelial cells induced low grade inflammation and metabolic syndrome, which was reversed by antibiotics, implying a connection with the gut microbiota (213).”
BackgroundFarnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity
Prawitt, J., Abdelkarim, M., Stroeve, J. H. M., Popescu, I., Duez, H., Velagapudi, V. R., Dumont, J., Bouchaert, E., van Dijk, T. H., Lucas, A., et al. (2011) · Diabetes · doi:10.2337/db11-0030 · Cited by 326
Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes
Lagathu, C., Yvan-Charvet, L., Bastard, J.-P., Maachi, M., Quignard-Boulangé, A., Capeau, J., & Caron, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0335-z · Cited by 321
Cytokine Tuning of Intestinal Epithelial Function
Andrews, C., McLean, M. H., & Durum, S. K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01270 · Cited by 319
Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians
Allaband, C., McDonald, D., Vázquez-Baeza, Y., Minich, J. J., Tripathi, A., Brenner, D. A., Loomba, R., Smarr, L., Sandborn, W. J., Schnabl, B., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.09.017 · Cited by 318
The Intestinal Epithelium: Central Coordinator of Mucosal Immunity
Allaire, J. M., Crowley, S. M., Law, H. T., Chang, S.-Y., Ko, H.-J., & Vallance, B. A. (2019) · Trends in Immunology · doi:10.1016/j.it.2018.12.008 · Cited by 315
Self-citationObstfeld, A. E., Sugaru, E., Thearle, M., Francisco, A.-M., Gayet, C., Ginsberg, H. N., Ables, E. V., & Ferrante, A. W. (2010) · Diabetes · doi:10.2337/db09-1403 · Cited by 314
Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease
Fouts, D. E., Torralba, M., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.019 · Cited by 311 · cited 1×
“Many pathologies, including inflammatory bowel disease (172), liver diseases (173), and metabolic syndrome (114), show signs of a disturbed gut barrier function leading to bacterial translocation (174).”
BackgroundChen, L., Wilson, J. E., Koenigsknecht, M. J., Chou, W.-C., Montgomery, S. A., Truax, A. D., Brickey, W. J., Packey, C. D., Maharshak, N., Matsushima, G. K., et al. (2017) · Nature Immunology · doi:10.1038/ni.3690 · Cited by 310 · cited 2×
“It has been shown to dampen and resolve inflammation, in particular in the intestine, in a microbiota dependent manner (228) and by promoting the growth of beneficial bacteria (228).”
BackgroundUbeda, C., Lipuma, L., Gobourne, A., Viale, A., Leiner, I., Equinda, M., Khanin, R., & Pamer, E. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120504 · Cited by 310 · cited 1×
“Importantly, follow-up studies suggest that the observed metabolic changes were likely due to housing techniques rather than the genetic profile (212).”
Backgroundde Groot, P., Scheithauer, T., Bakker, G. J., Prodan, A., Levin, E., Khan, M. T., Herrema, H., Ackermans, M., Serlie, M. J. M., de Brauw, M., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-318320 · Cited by 309
Self-citationGalazzo, G., van Best, N., Bervoets, L., Dapaah, I. O., Savelkoul, P. H., Hornef, M. W., Hutton, E. K., Morrison, K., Holloway, A. C., McDonald, H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.024 · Cited by 308
Kang, Y. E., Kim, J. M., Joung, K. H., Lee, J. H., You, B. R., Choi, M. J., Ryu, M. J., Ko, Y. B., Lee, M. A., Lee, J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154003 · Cited by 306 · cited 1×
“Monocyte chemoattractant protein-1 (MCP1) is a strong chemokine for monocytes (35), and its expression was increased in obese human (36) and rodent adipose tissue (37, 38).”
BackgroundPlasticity of innate lymphoid cell subsets
Bal, S. M., Golebski, K., & Spits, H. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0282-9 · Cited by 304
Lee, B.-C., Kim, M.-S., Pae, M., Yamamoto, Y., Eberlé, D., Shimada, T., Kamei, N., Park, H.-S., Sasorith, S., Woo, J. R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.002 · Cited by 303
Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation
Agudelo, L. Z., Ferreira, D. M. S., Cervenka, I., Bryzgalova, G., Dadvar, S., Jannig, P. R., Pettersson-Klein, A. T., Lakshmikanth, T., Sustarsic, E. G., Porsmyr-Palmertz, M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.004 · Cited by 302
Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Man, S. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0054-1 · Cited by 302
Commensal Fungi Recapitulate the Protective Benefits of Intestinal Bacteria
Jiang, T. T., Shao, T.-Y., Ang, W. X. G., Kinder, J. M., Turner, L. H., Pham, G., Whitt, J., Alenghat, T., & Way, S. S. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.10.013 · Cited by 301
Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy
Serrano, M. G., Parikh, H. I., Brooks, J. P., Edwards, D. J., Arodz, T. J., Edupuganti, L., Huang, B., Girerd, P. H., Bokhari, Y. A., Bradley, S. P., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0465-8 · Cited by 300
Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health
Laurans, L., Venteclef, N., Haddad, Y., Chajadine, M., Alzaid, F., Metghalchi, S., Sovran, B., Denis, R. G. P., Dairou, J., Cardellini, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0060-4 · Cited by 300
Glatz, J. C., & Luiken, J. F. P. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r082933 · Cited by 299
Ruan, H., Miles, P. D. G., Ladd, C. M., Ross, K., Golub, T. R., Olefsky, J. M., & Lodish, H. F. (2002) · Diabetes · doi:10.2337/diabetes.51.11.3176 · Cited by 295
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., & Donath, M. Y. (2012) · Diabetes Care · doi:10.2337/dc11-2219 · Cited by 294
Adipose-resident group 1 innate lymphoid cells promote obesity-associated insulin resistance
O’Sullivan, T. E., Rapp, M., Fan, X., Weizman, O.-E., Bhardwaj, P., Adams, N. M., Walzer, T., Dannenberg, A. J., & Sun, J. C. (2016) · Immunity · doi:10.1016/j.immuni.2016.06.016 · Cited by 293
Tirosh, A., Calay, E. S., Tuncman, G., Claiborn, K. C., Inouye, K. E., Eguchi, K., Alcala, M., Rathaus, M., Hollander, K. S., Ron, I., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav0120 · Cited by 291
Evidence for greater production of colonic short-chain fatty acids in overweight than lean humans
Rahat-Rozenbloom, S., Fernandes, J., Gloor, G. B., & Wolever, T. M. S. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.46 · Cited by 290
Human Pancreatic Islets Produce and Secrete MCP-1/CCL2: Relevance in Human Islet Transplantation
Piemonti, L., Leone, B. E., Nano, R., Saccani, A., Monti, P., Maffi, P., Bianchi, G., Sica, A., Peri, G., Melzi, R., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.1.55 · Cited by 287
Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women
Sumarac-Dumanovic, M., Stevanovic, D., Ljubic, A., Jorga, J., Simic, M., Stamenkovic-Pejkovic, D., Starcevic, V, Trajkovic, V, & Micic, D. (2009) · International Journal of Obesity · doi:10.1038/ijo.2008.216 · Cited by 286
Dominguez, H., Storgaard, H., Rask-Madsen, C., Steffen Hermann, T., Ihlemann, N., Baunbjerg Nielsen, D., Spohr, C., Kober, L., Vaag, A., & Torp-Pedersen, C. (2005) · Journal of Vascular Research · doi:10.1159/000088261 · Cited by 286
Toll-like Receptor Status in Obesity and Metabolic Syndrome: A Translational Perspective
Jialal, I., Kaur, H., & Devaraj, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3092 · Cited by 285
Forgotten fungi—the gut mycobiome in human health and disease
Huseyin, C. E., O’Toole, P. W., Cotter, P. D., & Scanlan, P. D. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw047 · Cited by 278
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Meijnikman, A. S., Gerdes, V. E., Nieuwdorp, M., & Herrema, H. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00192 · Cited by 278
Self-citationMacrophages in obesity and non-alcoholic fatty liver disease: crosstalk with metabolism
Lefere, S., & Tacke, F. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.02.004 · Cited by 278
Tumor necrosis factor alpha -induced activation of c-jun N-terminal kinase is mediated by TRAF2
Reinhard, C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.5.1080 · Cited by 276
Innate Lymphoid Cells in Mucosal Immunity
Panda, S. K., & Colonna, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00861 · Cited by 275
Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats
Cani, P. D., Hoste, S., Guiot, Y., & Delzenne, N. M. (2007) · British Journal of Nutrition · doi:10.1017/s0007114507691648 · Cited by 274
Peyrin-Biroulet, L., Gonzalez, F., Dubuquoy, L., Rousseaux, C., Dubuquoy, C., Decourcelle, C., Saudemont, A., Tachon, M., Béclin, E., Odou, M.-F., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300370 · Cited by 274
Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review
Rheinheimer, J., de Souza, B. M., Cardoso, N. S., Bauer, A. C., & Crispim, D. (2017) · Metabolism · doi:10.1016/j.metabol.2017.06.002 · Cited by 273
Microbial antigen encounter during a preweaning interval is critical for tolerance to gut bacteria
Knoop, K. A., Gustafsson, J. K., McDonald, K. G., Kulkarni, D. H., Coughlin, P. E., McCrate, S., Kim, D., Hsieh, C.-S., Hogan, S. P., Elson, C. O., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aao1314 · Cited by 270
van den Munckhof, I. C. L., Kurilshikov, A., ter Horst, R., Riksen, N. P., Joosten, L. A. B., Zhernakova, A., Fu, J., Keating, S. T., Netea, M. G., de Graaf, J., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12750 · Cited by 270
Interleukin-6 regulates pancreatic α-cell mass expansion
Ellingsgaard, H., Ehses, J. A., Hammar, E. B., Van Lommel, L., Quintens, R., Martens, G., Kerr-Conte, J., Pattou, F., Berney, T., Pipeleers, D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801059105 · Cited by 269
Adaptive immune education by gut microbiota antigens
Zhao, Q., & Elson, C. O. (2018) · Immunology · doi:10.1111/imm.12896 · Cited by 268
Hasnain, S. Z., Borg, D. J., Harcourt, B. E., Tong, H., Sheng, Y. H., Ng, C. P., Das, I., Wang, R., Chen, A. C.-H., Loudovaris, T., et al. (2014) · Nature Medicine · doi:10.1038/nm.3705 · Cited by 263
Mobini, R., Tremaroli, V., Ståhlman, M., Karlsson, F., Levin, M., Ljungberg, M., Sohlin, M., Bertéus Forslund, H., Perkins, R., Bäckhed, F., et al. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12861 · Cited by 263
Kupffer cell activation is a causal factor for hepatic insulin resistance
Lanthier, N., Molendi-Coste, O., Horsmans, Y., van Rooijen, N., Cani, P. D., & Leclercq, I. A. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00391.2009 · Cited by 257
Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model
Rasmussen, T. S., Mentzel, C. M. J., Kot, W., Castro-Mejía, J. L., Zuffa, S., Swann, J. R., Hansen, L. H., Vogensen, F. K., Hansen, A. K., & Nielsen, D. S. (2020) · Gut · doi:10.1136/gutjnl-2019-320005 · Cited by 255
Watanabe, M., Horai, Y., Houten, S. M., Morimoto, K., Sugizaki, T., Arita, E., Mataki, C., Sato, H., Tanigawara, Y., Schoonjans, K., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248203 · Cited by 254
Simon, M.-C., Strassburger, K., Nowotny, B., Kolb, H., Nowotny, P., Burkart, V., Zivehe, F., Hwang, J.-H., Stehle, P., Pacini, G., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2690 · Cited by 253
NOD1 activators link innate immunity to insulin resistance
Schertzer, J. D., Tamrakar, A. K., Magalhães, J. G., Pereira, S., Bilan, P. J., Fullerton, M. D., Liu, Z., Steinberg, G. R., Giacca, A., Philpott, D. J., et al. (2011) · Diabetes · doi:10.2337/db11-0004 · Cited by 253
Inouye, K. E., Shi, H., Howard, J. K., Daly, C. H., Lord, G. M., Rollins, B. J., & Flier, J. S. (2007) · Diabetes · doi:10.2337/db07-0425 · Cited by 252
Dalmas, E., Venteclef, N., Caer, C., Poitou, C., Cremer, I., Aron-Wisnewsky, J., Lacroix-Desmazes, S., Bayry, J., Kaveri, S. V., Clément, K., et al. (2014) · Diabetes · doi:10.2337/db13-1511 · Cited by 240
Everard, A., Geurts, L., Caesar, R., Van Hul, M., Matamoros, S., Duparc, T., Denis, R. G. P., Cochez, P., Pierard, F., Castel, J., et al. (2014) · Nature Communications · doi:10.1038/ncomms6648 · Cited by 237
Commensal Candida albicans Positively Calibrates Systemic Th17 Immunological Responses
Shao, T.-Y., Ang, W. X. G., Jiang, T. T., Huang, F. S., Andersen, H., Kinder, J. M., Pham, G., Burg, A. R., Ruff, B., Gonzalez, T., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.02.004 · Cited by 237
Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases
Taleb, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02113 · Cited by 236
Harte, A. L., Varma, M. C., Tripathi, G., McGee, K. C., Al-Daghri, N. M., Al-Attas, O. S., Sabico, S., O’Hare, J. P., Ceriello, A., Saravanan, P., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1593 · Cited by 235
Multicenter Trial of a Combination Probiotic for Children with Gastroenteritis
Freedman, S. B., Williamson-Urquhart, S., Farion, K. J., Gouin, S., Willan, A. R., Poonai, N., Hurley, K., Sherman, P. M., Finkelstein, Y., Lee, B. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802597 · Cited by 234
Muramyl Dipeptide-Based Postbiotics Mitigate Obesity-Induced Insulin Resistance via IRF4
Cavallari, J. F., Fullerton, M. D., Duggan, B. M., Foley, K. P., Denou, E., Smith, B. K., Desjardins, E. M., Henriksbo, B. D., Kim, K. J., Tuinema, B. R., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.021 · Cited by 232
Diabetes and branched‐chain amino acids: What is the link?: 糖尿病与支链氨基酸:有什么关联吗?
Bloomgarden, Z. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12645 · Cited by 229
Truax, A. D., Chen, L., Tam, J. W., Cheng, N., Guo, H., Koblansky, A. A., Chou, W.-C., Wilson, J. E., Brickey, W. J., Petrucelli, A., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.08.009 · Cited by 228
Kleinschek, M. A., Muller, U., Brodie, S. J., Stenzel, W., Kohler, G., Blumenschein, W. M., Straubinger, R. K., McClanahan, T., Kastelein, R. A., & Alber, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.1098 · Cited by 227
Microbiota and metabolites in metabolic diseases
Cani, P. D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0143-9 · Cited by 221
Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients
Michalovich, D., Rodriguez-Perez, N., Smolinska, S., Pirozynski, M., Mayhew, D., Uddin, S., Van Horn, S., Sokolowska, M., Altunbulakli, C., Eljaszewicz, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13751-9 · Cited by 213
Ruan, Y., Sun, J., He, J., Chen, F., Chen, R., & Chen, H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132121 · Cited by 210
Gut-associated IgA+ immune cells regulate obesity-related insulin resistance
Luck, H., Khan, S., Kim, J. H., Copeland, J. K., Revelo, X. S., Tsai, S., Chakraborty, M., Cheng, K., Tao Chan, Y., Nøhr, M. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11370-y · Cited by 205
McGillicuddy, F. C., Harford, K. A., Reynolds, C. M., Oliver, E., Claessens, M., Mills, K. H. G., & Roche, H. M. (2011) · Diabetes · doi:10.2337/db10-1278 · Cited by 199
IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM
Catanzaro, J. R., Strauss, J. D., Bielecka, A., Porto, A. F., Lobo, F. M., Urban, A., Schofield, W. B., & Palm, N. W. (2019) · Scientific Reports · doi:10.1038/s41598-019-49923-2 · Cited by 198
Fuel utilization in colonocytes of the rat
Ardawi, M. S. M., & Newsholme, E. A. (1985) · Biochemical Journal · doi:10.1042/bj2310713 · Cited by 196
Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted Cytotoxicity
Boulenouar, S., Michelet, X., Duquette, D., Alvarez, D., Hogan, A. E., Dold, C., O’Connor, D., Stutte, S., Tavakkoli, A., Winters, D., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.008 · Cited by 192
Denou, E., Lolmède, K., Garidou, L., Pomie, C., Chabo, C., Lau, T. C., Fullerton, M. D., Nigro, G., Zakaroff‐Girard, A., Luche, E., et al. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201404169 · Cited by 191
Gut microbiota and immune crosstalk in metabolic disease
Burcelin, R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.05.016 · Cited by 191
Causality of small and large intestinal microbiota in weight regulation and insulin resistance
Scheithauer, T. P. M., Dallinga-Thie, G. M., de Vos, W. M., Nieuwdorp, M., & van Raalte, D. H. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.002 · Cited by 188 · cited 2×
“Although a definition of a “healthy gutmicrobiota” is generally lacking, a plethora of disease conditions are associated with a microbiota composition that is different from a healthy control group (124, 146).”
BackgroundSelf-citationLin, M. Y., de Zoete, M. R., van Putten, J. P. M., & Strijbis, K. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00554 · Cited by 186
Beserra, B. T. S., Fernandes, R., do Rosario, V. A., Mocellin, M. C., Kuntz, M. G. F., & Trindade, E. B. S. M. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.10.004 · Cited by 182
Nlrp6- and ASC-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition
Mamantopoulos, M., Ronchi, F., Van Hauwermeiren, F., Vieira-Silva, S., Yilmaz, B., Martens, L., Saeys, Y., Drexler, S. K., Yazdi, A. S., Raes, J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.011 · Cited by 181
Fatkhullina, A. R., Peshkova, I. O., Dzutsev, A., Aghayev, T., McCulloch, J. A., Thovarai, V., Badger, J. H., Vats, R., Sundd, P., Tang, H.-Y., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.011 · Cited by 181
FoxO1 Links Insulin Resistance to Proinflammatory Cytokine IL-1β Production in Macrophages
Su, D., Coudriet, G. M., Hyun Kim, D., Lu, Y., Perdomo, G., Qu, S., Slusher, S., Tse, H. M., Piganelli, J., Giannoukakis, N., et al. (2009) · Diabetes · doi:10.2337/db09-0232 · Cited by 180
Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes
Lü, J., Zhao, J., Meng, H., & Zhang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01173 · Cited by 179
Heianza, Y., Sun, D., Li, X., DiDonato, J. A., Bray, G. A., Sacks, F. M., & Qi, L. (2019) · Gut · doi:10.1136/gutjnl-2018-316155 · Cited by 177
Duparc, T., Plovier, H., Marrachelli, V. G., Van Hul, M., Essaghir, A., Ståhlman, M., Matamoros, S., Geurts, L., Pardo-Tendero, M. M., Druart, C., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310904 · Cited by 177
The Western lifestyle has lasting effects on metaflammation
Christ, A., & Latz, E. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0156-1 · Cited by 177
Systemic inflammation and insulin sensitivity in obese IFN-γ knockout mice
O'Rourke, R. W., White, A. E., Metcalf, M. D., Winters, B. R., Diggs, B. S., Zhu, X., & Marks, D. L. (2012) · Metabolism · doi:10.1016/j.metabol.2012.01.018 · Cited by 174
β-Defensins: Farming the Microbiome for Homeostasis and Health
Meade, K. G., & O'Farrelly, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03072 · Cited by 172
Marfella, R., Esposito, K., Siniscalchi, M., Cacciapuoti, F., Giugliano, F., Labriola, D., Ciotola, M., Di Palo, C., Misso, L., & Giugliano, D. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.47 · Cited by 170 · cited 1×
“Interestingly, a 10% weight loss reduced plasma concentrations of several cytokines in obese women (10).”
BackgroundYao, K., Zeng, L., He, Q., Wang, W., Lei, J., & Zou, X. (2017) · Medical Science Monitor · doi:10.12659/msm.902600 · Cited by 170
The evolution of innate lymphoid cells
Vivier, E., van de Pavert, S. A., Cooper, M. D., & Belz, G. T. (2016) · Nature Immunology · doi:10.1038/ni.3459 · Cited by 170
Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis
Tsao, C.-H., Shiau, M., Chuang, P.-H., Chang, Y.-H., & Hwang, J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m041392 · Cited by 168
Mishima, Y., Oka, A., Liu, B., Herzog, J. W., Eun, C. S., Fan, T.-J., Bulik-Sullivan, E., Carroll, I. M., Hansen, J. J., Chen, L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci93820 · Cited by 166 · cited 1×
“For example, IL-10 is important to dampen an inflammatory response against intestinal bacteria (265).”
BackgroundOverexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice
Franckhauser, S., Elias, I., Rotter Sopasakis, V., Ferré, T., Nagaev, I., Andersson, C. X., Agudo, J., Ruberte, J., Bosch, F., & Smith, U. (2008) · Diabetologia · doi:10.1007/s00125-008-0998-8 · Cited by 165
Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity
Jørgensen, S. B., O’Neill, H. M., Sylow, L., Honeyman, J. E., Hewitt, K. A., Palanivel, R., Fullerton, M. D., Öberg, L., Balendran, A., Galić, S., et al. (2012) · Diabetes · doi:10.2337/db12-0443 · Cited by 162
Probiotics for weight loss: a systematic review and meta-analysis
Park, S., & Bae, J.-H. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.05.008 · Cited by 161
Plomgaard, P., Nielsen, A. R., Fischer, C. P., Mortensen, O. H., Broholm, C., Penkowa, M., Krogh-Madsen, R., Erikstrup, C., Lindegaard, B., Petersen, A. M. W., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0834-6 · Cited by 152 · cited 1×
“Tumor necrosis factor (TNF), which is mostly expressed and secreted by adipose tissue macrophages (59), was one of the first cytokines shown to be increased in adipose tissue (60) and circulation of people with T2D and obesity (61).”
BackgroundMetghalchi, S., Ponnuswamy, P., Simon, T., Haddad, Y., Laurans, L., Clément, M., Dalloz, M., Romain, M., Esposito, B., Koropoulis, V., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.004 · Cited by 143
Do antibodies select a healthy microbiota?
Kubinak, J. L., & Round, J. L. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.114 · Cited by 142
Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage
Contreras, O. M., Harusato, A., Nishio, H., Flannigan, K. L., Ngo, V. L., Leoni, G., Neumann, P.-A., Geem, D., Lili, L. N., Ramadas, R. A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501312 · Cited by 140
Tran, H. Q., Ley, R. E., Gewirtz, A. T., & Chassaing, B. (2019) · Nature Communications · doi:10.1038/s41467-019-13538-y · Cited by 136
Miani, M., Naour, J. L., Waeckel-Énée, E., Verma, S. C., Straube, M., Emond, P., Ryffel, B., Endert, P. V., Sokol, H., & Diana, J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.012 · Cited by 133
Martin, A. P., Rankin, S. M., Pitchford, S. C., Charo, I. F., Furtado, G. C., & Lira, S. A. (2008) · Diabetes · doi:10.2337/db08-0625 · Cited by 132
Ngo, V. L., Abo, H., Maxim, E., Harusato, A., Geem, D., Contreras, O. M., Merlin, D., Gewirtz, A. T., Nusrat, A., & Denning, T. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718902115 · Cited by 130
Acute Modulation of Toll-Like Receptors by Insulin
Ghanim, H., Mohanty, P., Deopurkar, R., Sia, C. L., Korzeniewski, K., Abuaysheh, S., Chaudhuri, A., & Dandona, P. (2008) · Diabetes Care · doi:10.2337/dc08-0561 · Cited by 125
Liver macrophages regulate systemic metabolism through non-inflammatory factors
Morgantini, C., Jager, J., Li, X., Levi, L., Azzimato, V., Sulen, A., Barreby, E., Xu, C., Tencerová, M., Näslund, E. B., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0044-9 · Cited by 124
Sun, J., & Buys, N. J. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516000076 · Cited by 122
Akbari, V., & Hendijani, F. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw039 · Cited by 121
Probiotics for the management of type 2 diabetes mellitus: A systematic review and meta-analysis
Samah, S., Ramasamy, K., Lim, S. M., & Neoh, C. F. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.06.014 · Cited by 112
Management of hyperglycaemia in type 2 diabetes: the end of recurrent failure?
Heine, R. J., Diamant, M., Mbanya, J. C., & Nathan, D. M. (2006) · BMJ · doi:10.1136/bmj.39022.462546.80 · Cited by 112
Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity
Wang, H., Shen, L., Sun, X., Liu, F., Feng, W., Jiang, C., Chu, X., Ye, X., Jiang, C., Wang, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11270-1 · Cited by 111
IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB
Victor, A. R., Nalin, A. P., Dong, W., McClory, S., Wei, M., Mao, C., Kladney, R. D., Youssef, Y., Chan, W. K., Briercheck, E. L., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601554 · Cited by 108
Flores-Guerrero, J. L., Osté, M. C. J., Kieneker, L. M., Gruppen, E. G., Wolak, J. E., Otvos, J. D., Connelly, M. A., Bakker, S. J. L., & Dullaart, R. P. F. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7120513 · Cited by 106
Watanabe, Y., Nagai, Y., & Takatsu, K. (2013) · Nutrients · doi:10.3390/nu5093757 · Cited by 101
NLR-Dependent Regulation of Inflammation in Multiple Sclerosis
Gharagozloo, M., Gris, K. V., Mahvelati, T. M., Amrani, A., Lukens, J. R., & Gris, D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.02012 · Cited by 101
Xu, E., Pereira, M. M. A., Karakasilioti, I., Theurich, S., Al-Maarri, M., Rappl, G., Waisman, A., Wunderlich, F. T., & Brüning, J. C. (2017) · Nature Communications · doi:10.1038/ncomms14803 · Cited by 100
The NLR Protein NLRP6 Does Not Impact Gut Microbiota Composition
Lemire, P., Robertson, S. J., Maughan, H., Tattoli, I., Streutker, C. J., Platnich, J. M., Muruve, D. A., Philpott, D. J., & Girardin, S. E. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.12.026 · Cited by 98 · cited 2×
“Two later studies highlight the importance of using proper controls, namely related littermates from the knock out mice, to exclude the influence of housing conditions and other genetic variations in the littermates (236, 237).”
BackgroundKwon, G., Xu, G. H., Marshall, C. A., & McDaniel, M. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18702 · Cited by 89
Postprandial leukocyte increase in healthy subjects
van Oostrom, A. J. H. H. M., Sijmonsma, T., Rabelink, T. J., van Asbeck, B. S., & Cabezas, M. C. (2003) · Metabolism · doi:10.1053/meta.2003.50037 · Cited by 76
Westwell-Roper, C. Y., Nąckiewicz, D., Dan, M., & Ehses, J. A. (2014) · Immunology and Cell Biology · doi:10.1038/icb.2014.4 · Cited by 75
The emergence of the IL‐36 cytokine family as novel targets for inflammatory diseases
Walsh, P. T., & Fallon, P. G. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13280 · Cited by 74
Zhang, Q., Pan, Y., Zeng, B., Zheng, X., Wang, H., Shen, X., Li, H., Jiang, Q., Zhao, J., Meng, Z.-X., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0190-3 · Cited by 73
Giannoudaki, E., Hernandez-Santana, Y., Mulfaul, K., Doyle, S., Hams, E., Fallon, P. G., Mat, A., O'Shea, D. B., Köpf, M., Hogan, A. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11944-w · Cited by 72
Timper, K., Dalmas, E., Dror, E., Rütti, S., Thienel, C., Sauter, N. S., Bouzakri, K., Bédat, B., Pattou, F., Kerr-Conte, J., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.003 · Cited by 67
Ji, Y., Sun, S., Shrestha, N., Darragh, L. B., Shirakawa, J., Xing, Y., He, Y., Carboneau, L., Kim, H., An, D., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0396-z · Cited by 64
Intestinal Ralstonia pickettii augments glucose intolerance in obesity
Udayappan, S., Kovatcheva-Datchary, P., Bakker, G., Havik, S., Herrema, H., Cani, P. D., Bouter, K., Belzer, C., Witjes, J. J., Vrieze, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181693 · Cited by 59
Self-citationZiblat, A., Núñez, S. Y., Iraolagoitia, X. L. R., Spallanzani, R. G., Torres, N. I., Sierra, J. M., Secchiari, F., Domaica, C. I., Fuertes, M. B., & Zwirner, N. W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01959 · Cited by 52
Martínez‐Reyes, C. P., Gómez-Arauz, A. Y., Torres-Castro, I., Manjarrez‐Reyna, A. N., Palomera, L. F., Olivos‐García, A., Mendoza-Tenorio, E., Medina, G. A. S., Islas‐Andrade, S., Meléndez, G., et al. (2018) · Journal of Diabetes Research · doi:10.1155/2018/7209872 · Cited by 49
Successful Treatment of Immune Checkpoint Inhibitor–Induced Diabetes With Infliximab
Trinh, B., Donath, M. Y., & Laubli, H. P. (2019) · Diabetes Care · doi:10.2337/dc19-0908 · Cited by 48
Sabapathy, V., Stremska, M., Mohammad, S., Corey, R., Sharma, P. R., & Sharma, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00572 · Cited by 45
Martins, L. M. S., Pérez, M. M., Pereira, C. A., Costa, F. R. C., Dias, M. S., Tostes, R. C., Ramos, S. G., de Zoete, M. R., Ryffel, B., Silva, J. S., et al. (2018) · Immunology · doi:10.1111/imm.12946 · Cited by 40
TLR4 is required for the obesity-induced pancreatic beta cell dysfunction
Li, J., Chen, L., Zhang, Y., Zhang, W. J., Xu, W., Qin, Y., Xu, J., & Zou, D. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt092 · Cited by 39
Bakker, G. J., Schnitzler, J. G., Bekkering, S., de Clercq, N. C., Koopen, A. M., Hartstra, A. V., Meessen, E. C. E., Scheithauer, T. P. M., Winkelmeijer, M., Dallinga‐Thie, G. M., et al. (2019) · Physiological Reports · doi:10.14814/phy2.14199 · Cited by 16
Self-citationInterleukin 22 disrupts pancreatic function in newborn mice expressing IL-23
Chen, L., Strohmeier, V., He, Z., Deshpande, M., Catalan‐Dibene, J., Durum, S. K., Moran, T. M., Kraus, T., Xiong, H., Faith, J. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12540-8 · Cited by 11
Cited by
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
The gut microbiome as a modulator of healthy ageing
Ghosh, T. S., Shanahan, F., & O’Toole, P. W. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00605-x · Cited by 817
Intestinal Barrier in Human Health and Disease
Di Tommaso, N., Gasbarrini, A., & Ponziani, F. R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312836 · Cited by 533
Li, H.-Y., Zhou, D.-D., Gan, R.-Y., Huang, S.-Y., Zhao, C.-N., Shang, A., Xu, X.-Y., & Li, H.-B. (2021) · Nutrients · doi:10.3390/nu13093211 · Cited by 490
Zoccali, C., Mallamaci, F., Adamczak, M., de Oliveira, R. B., Massy, Z. A., Sarafidis, P., Agarwal, R., Mark, P. B., Kotanko, P., Ferro, C. J., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad083 · Cited by 363
Metadata
- Authors
- Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-10-16
- Volume
- 11
- Pages
- 571731-571731
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3097882759
- Cited by
- 673
- References
- 361
- FWCI
- 20.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.